Shannon R. Cope

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

One-step parametric network meta-analysis models using the exact likelihood that allow for time-varying treatment effects.

One-step parametric network meta-analysis models using the exact likelihood that allow for time-varying treatment effects.

Journal: Research synthesis methods

Published: February 02, 2026

Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Relapsed/Refractory Acute Myeloid Leukemia.

Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Relapsed/Refractory Acute Myeloid Leukemia.

Journal: Advances in therapy

Published: December 17, 2025

Augmented two-stage estimation for treatment switching in oncology trials: Leveraging external data for improved precision.

Augmented two-stage estimation for treatment switching in oncology trials: Leveraging external data for improved precision.

Journal: Statistical methods in medical research

Published: September 30, 2025

Population-adjusted unanchored indirect comparisons of cancer therapies with borrowing of pan-tumor information.

Population-adjusted unanchored indirect comparisons of cancer therapies with borrowing of pan-tumor information.

Journal: Statistical methods in medical research

Published: July 04, 2025

Joint modeling of progression-free survival and patient-reported outcomes to evaluate the association between disease progression and symptoms among patients with relapsed/refractory multiple myeloma.

Joint modeling of progression-free survival and patient-reported outcomes to evaluate the association between disease progression and symptoms among patients with relapsed/refractory multiple myeloma.

Journal: Journal of patient-reported outcomes

Published: February 06, 2025

Implementing Multilevel Network Meta-Regression for Time-To-Event Outcomes: A Case Study in Relapsed Refractory Multiple Myeloma.

Implementing Multilevel Network Meta-Regression for Time-To-Event Outcomes: A Case Study in Relapsed Refractory Multiple Myeloma.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: August 29, 2023

An indirect treatment comparison of efficacy and health-related quality of life following treatment with idecabtagene vicleucel versus belantamab mafodotin in triple-class exposed relapsed/refractory patients with multiple myeloma.

An indirect treatment comparison of efficacy and health-related quality of life following treatment with idecabtagene vicleucel versus belantamab mafodotin in triple-class exposed relapsed/refractory patients with multiple myeloma.

Journal: Leukemia & lymphoma

Published: July 27, 2023

Unanchored Population-Adjusted Indirect Comparison Methods for Time-to-Event Outcomes Using Inverse Odds Weighting, Regression Adjustment, and Doubly Robust Methods With Either Individual Patient or Aggregate Data.

Unanchored Population-Adjusted Indirect Comparison Methods for Time-to-Event Outcomes Using Inverse Odds Weighting, Regression Adjustment, and Doubly Robust Methods With Either Individual Patient or Aggregate Data.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: March 10, 2023

A Comparison of Alternative Network Meta-Analysis Methods in the Presence of Nonproportional Hazards: A Case Study in First-Line Advanced or Metastatic Renal Cell Carcinoma.

A Comparison of Alternative Network Meta-Analysis Methods in the Presence of Nonproportional Hazards: A Case Study in First-Line Advanced or Metastatic Renal Cell Carcinoma.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: May 09, 2022

Indirect treatment comparison of idecabtagene vicleucel versus conventional care in triple-class exposed multiple myeloma.

Indirect treatment comparison of idecabtagene vicleucel versus conventional care in triple-class exposed multiple myeloma.

Journal: Journal of comparative effectiveness research

Published: April 29, 2022

Structured expert elicitation to inform long-term survival extrapolations using alternative parametric distributions: a case study of CAR T therapy for relapsed/ refractory multiple myeloma.

Structured expert elicitation to inform long-term survival extrapolations using alternative parametric distributions: a case study of CAR T therapy for relapsed/ refractory multiple myeloma.

Journal: BMC medical research methodology

Published: February 16, 2022

Cost-effectiveness analysis of cemiplimab vs pembrolizumab for treatment of advanced cutaneous squamous cell carcinoma.

Cost-effectiveness analysis of cemiplimab vs pembrolizumab for treatment of advanced cutaneous squamous cell carcinoma.

Journal: Journal of managed care & specialty pharmacy

Published: August 05, 2021

Showing 1-12 of 38

Last Updated: 09/26/2026